NeoClinical Research

Futó vizsgálatok

• Toboroz

  LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  NCT07186101· 2. fázis· Forrás

• Toboroz

  A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  NCT06857942· 4. fázis· Forrás

• Fut, nem toboroz

  An Open-Label Study of Azetukalner in Major Depressive Disorder

  NCT06922110· 3. fázis· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· 3. fázis· Forrás

• Fut, nem toboroz

  A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  NCT06775379· 3. fázis· Forrás

• Toboroz

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· 3. fázis· Forrás

• Toboroz

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Zsírmáj (MASLD/MASH)2 toboroz
• Colitis ulcerosa1 toboroz
• Crohn-betegség1 toboroz
• Elhízás1 toboroz
• Liver cirrhosis1 toboroz
• Pikkelysömör1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

  NCT06588283· 3. fázis· Forrás

• Lezárult

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

  NCT06588296· 3. fázis· Forrás